Literature DB >> 19362593

Selective presynaptic degeneration in the synaptopathy associated with ME7-induced hippocampal pathology.

Bryony C Gray1, Zuzana Siskova, V Hugh Perry, Vincent O'Connor.   

Abstract

Intrahippocampal injection of the murine modified scrapie (ME7) induces a model of prion disease in vivo. Animals inoculated with ME7 brain homogenate were compared to controls at 8, 12 and 21 weeks. The data show that the accumulation of misfolded prion (PrP(Sc)) coincided with selective reduction in presynaptic protein expression early in disease. This loss is independent of a change in the number of cell bodies in CA3 that provide the major presynaptic input to the stratum radiatum. Electron microscopy of the stratum radiatum independently evidenced a progressive decrease in the number of synapses during disease. Further, the number of postsynaptic specializations lacking an intact presynaptic specialization increased from 12 to 21 weeks. This suggests that the presynaptic compartment is selectively disrupted when the previously reported first behavioural deficits are observed in this model. This synaptic pathology or "synaptopathy" may represent the earliest neuronal dysfunction in this and other protein misfolding induced neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362593     DOI: 10.1016/j.nbd.2009.04.001

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  43 in total

Review 1.  Allosteric function and dysfunction of the prion protein.

Authors:  Rafael Linden; Yraima Cordeiro; Luis Mauricio T R Lima
Journal:  Cell Mol Life Sci       Date:  2011-10-09       Impact factor: 9.261

2.  Microdissection and transcriptional profiling: a window into the pathobiology of preclinical prion disease.

Authors:  Anna Majer; Stephanie A Booth
Journal:  Prion       Date:  2014 Jan-Feb       Impact factor: 3.931

3.  PrPSc accumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases.

Authors:  Stephen J Dearmond; Krystyna Bajsarowicz
Journal:  Mol Neurodegener       Date:  2010-01-21       Impact factor: 14.195

4.  HIV and SIV induce alterations in CNS CaMKII expression and activation: a potential mechanism for cognitive impairment.

Authors:  Ravi G Gupta; Kathleen M Kelly; Kris L Helke; Suzanne E Queen; Jami M Karper; Jamie L Dorsey; Angela K Brice; Robert J Adams; Patrick M Tarwater; Dennis L Kolson; Joseph L Mankowski
Journal:  Am J Pathol       Date:  2010-04-09       Impact factor: 4.307

5.  Comparison of abnormal isoform of prion protein in prion-infected cell lines and primary-cultured neurons by PrPSc-specific immunostaining.

Authors:  Misaki Tanaka; Ai Fujiwara; Akio Suzuki; Takeshi Yamasaki; Rie Hasebe; Kentaro Masujin; Motohiro Horiuchi
Journal:  J Gen Virol       Date:  2016-06-06       Impact factor: 3.891

6.  Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping.

Authors:  Zuzana Sisková; Anton Page; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2009-09-24       Impact factor: 4.307

7.  Proteome Analysis of Potential Synaptic Vesicle Cycle Biomarkers in the Cerebrospinal Fluid of Patients with Sporadic Creutzfeldt-Jakob Disease.

Authors:  Chunyu Wang; Deming Zhao; Syed Zahid Ali Shah; Wei Yang; Chaosi Li; Lifeng Yang
Journal:  Mol Neurobiol       Date:  2016-08-25       Impact factor: 5.590

Review 8.  The role of microglia in synaptic stripping and synaptic degeneration: a revised perspective.

Authors:  V Hugh Perry; Vincent O'Connor
Journal:  ASN Neuro       Date:  2010-10-14       Impact factor: 4.146

9.  Plasma membrane invaginations containing clusters of full-length PrPSc are an early form of prion-associated neuropathology in vivo.

Authors:  Susan F Godsave; Holger Wille; Jason Pierson; Stanley B Prusiner; Peter J Peters
Journal:  Neurobiol Aging       Date:  2013-06       Impact factor: 4.673

10.  Silencing synapses: a route to understanding synapse degeneration in chronic neurodegenerative disease.

Authors:  Matteo Caleo; Laura Restani; V Hugh Perry
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.